Kathleen Overholt, MD

Bio

Dr. Overholt obtained her medical degreel from University of New Mexico School of Medicine and completed her pediatric residency at Wake Forrest Baptist Medical Center.  From there she chose to persue fellowship training at Nationwide Children's Hospital in the section of Hematology/Oncology/BMT where her research focused on  the bone marrow microenvironment during transplantation.  Currently her acedemaic and clinical interests include benign hematology, specifically cytopenias, immunohematology and bone marrow failure disorders.

Key Publications

Kathleen M Overholt, T. Guinipero, N. Heerema, M. Loken, and S. Kahwash. Promyelocytic Leukemia with No Retinoic Acid Receptor Alpha Abnormality but with RUNX1T1 Insertion to Chromosome 7q: A Classification and Management Dilemma. Case Reports in Hematology. Volume 2015 (2015), Article ID 412016

Satoru Otsuru; Kathleen M Overholt; Timothy S. Olson; Ted J Hofmann; Adam J Guess; Victoria M Velazquez; Takashi Kaito; Massimo Dominici; Edwin M Horwitz. Hematopoietic Derived Cells Do Not Contribute To Osteogenesis As Osteoblasts. Bone. 2016; 94:2017, 1–9

Kathleen M Overholt, Melissa J. Rose, Sarita Joshi, Gail E. Herman, Rajinder Bajwa, Rolla Abu-Arja, Hemalatha G. Rangarajan, Edwin M. Horwitz. Hematopoietic Cell Transplantation for a Child with OSTM1-Osteopetrosis.  Blood Advances 2017; 1:279-281

Kathleen M. Overholt, Satoru Otsuru, Timothy S. Olson, Adam J. Guess, Victoria M. Velazquez, Laura Desbourdes, Massimo Dominici, and Edwin M. Horwitz. Identification of a Murine CD45^neg F4/80^lo HSC-derived Marrow Endosteal Cell Associated with Donor Engraftment after HCT. Accepted for publication in Blood Advances on November 2017.